Table 6.
Cluster-ID | Size | Silhouette | Coverage | Label |
---|---|---|---|---|
0 | 142 | 0.616 | Oxidative stress; gene expression; cerebral ischemia; nitric oxide synthase; Alzheimer's disease | Oxidative stress |
1 | 111 | 0.736 | Prevalence; hyperinsulinemia; cardiovascular disease; population; risk factor | Prevalence |
2 | 82 | 0.715 | Adiponectin; resistin; ischemic stroke; inflammation; c reactive protein | Adiponectin |
3 | 80 | 0.787 | Low density lipoprotein; cardiovascular risk factor; coronary artery disease; von willebrand factor; risk | Low density lipoprotein |
4 | 78 | 0.627 | Therapy; hyperglycemia; stroke severity; interleukin-1; tissue plasminogen activator | Therapy |
5 | 56 | 0.799 | Secondary prevention; pioglitazone; clinical trial; transient ischemic attack; obesity | Secondary prevention |
6 | 46 | 0.791 | Diabetic cardiomyopathy; heart failure; trimetazidine; fatty acid oxidation; cardiomyopathy | Diabetic cardiomyopathy |
7 | 44 | 0.774 | Physical activity; randomized controlled trial; cardiac rehabilitation; fatty acid; neuroscience | Physical activity |
8 | 31 | 0.877 | Family history; hemostasis; factor alpha; thrombosis; plasminogen activator inhibitor 1 (pai-1) | Family history |
9 | 25 | 0.899 | Stroke mortality; transplantation; renal failure; kidney; cardiovascular disease (CVD) | Stroke mortality |
10 | 7 | 0.987 | Thyroid function; turner syndrome; PKC delta; puberty; genes | Thyroid function |